ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses

Wang, Yan; Chen, Zhengbo; Zhao, Gang; Li, Qiang*广东省人民医院; 南方医科大学; 中山大学
Mediators of Inflammation2023-4-25DOI: 10.1155/2023/3781091
1被引4阅读
引用收藏
分享

摘要

Colorectal carcinoma (CRC) is a malignant tumor of the digestive system. Cancer-associated fibroblasts (CAFs) are important cellular elements in the tumor microenvironment of CRC, which contribute to CRC progression and immune escape. To predict the survival outcome and therapeutic responses of CRC patients, we identified genes connected with stromal CAF and generated a risk model. In this study, we used multiple algorithms to reveal CAF-related genes in the Gene Expression Omnibus and The Cancer Genome Atlas datasets and construct a risk model composed by prognostic CAF-associated genes. Then, we evaluated whether the risk score could predict CAF infiltrations and immunotherapy in CRC and confirmed the expression of the risk model in CAFs. Our results showed that CRC patients with high CAF infiltrations and stromal score had worse prognosis than those with low-CAF infiltrations and stromal score. We obtained 88 stromal CAF-associated hub-genes and generated a CAF risk model consisting of ZNF532 and COLEC12. Compared with low-risk group, the overall survival in high-risk group was shorter. The relationship between risk score, ZNF532 and COLEC12, and stromal CAF infiltrations and CAF markers was positive. In addition, the effect of immunotherapy in the high-risk group was not as good as that in the low-risk group. Patients with the high-risk group were enriched in chemokine signaling pathway, cytokine-cytokine receptor interaction, and focal adhesion. Finally, we confirmed that the expressions of ZNF532 and COLEC12 in risk model were widely distributed in fibroblasts of CRC, and the expression levels were higher in fibroblasts than CRC cells. In conclusion, the prognostic CAF signature of ZNF532 and COLEC12 can be applied not only to predict the prognosis of CRC patients but also to evaluate the immunotherapy response in CRC patients, and these findings provide the possibility for further development of individualized treatment for CRC.

学科与关键词

关键词
ANGIOGENESISCELLS
相关
加载中…
  • A stromal and immune cell infiltration-based score model predicts prognosis and chemotherapy effect in colorectal cancer
    Luo, Qingqing; He, Feng*; Cao, Jie*International Immunopharmacology, 2021, 99: 107940.被引 4
  • Identification and Validation of a Novel Prognostic Gene Model for Colorectal Cancer
    Meng, Yan; Zhou, Rulin; Lin, Zhizhao; Peng, Qun; Ding, Jian; Huang, Mei; Li, Yiwen; Guo, Xuxue; Zhuang, Kangmin*Computational and Mathematical Methods in Medicine, 2022, 2022: 9774219.被引 1
  • Development of a Platelet-Related Prognostic Model for Colorectal Cancer
    Wang, Pengcheng*; Zhao, Wei; Cao, HaileiFrontiers in Genetics, 2022, 13: 904168.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Mediators of Inflammation
发表日期
2023-04-25
卷期
第 2023 卷
页码
3781091
DOI
10.1155/2023/3781091
语言
ENGLISH
成果收录
SCIE

作者

  • W

    Wang, Yan (第一作者)

    sun yat sen univ

  • C

    Chen, Zhengbo

    guangdong prov peoples hosp · southern med univ

查看全部 4 位作者收起作者
  • Z

    Zhao, Gang

    guangdong prov peoples hosp · southern med univ

  • L

    Li, Qiang (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417